Trump Signs Executive Order Imposing 100 Percent Tariff on Imported Brand Name Drugs

President Trump signed an executive order targeting imported brand name drugs with a 100 percent tariff, citing the U.S.'s heavy reliance on foreign imports as the primary justification. This move aims to reduce domestic dependence on overseas pharmaceuticals and potentially lower long-term costs by incentivizing domestic production. The decision is expected to spark immediate market volatility and debate over the impact on patient access to essential medications.